PartnershipJul 15, 2026, 07:31 AM
BriaCell Partners with FUJIFILM for Bria-IMT Manufacturing
AI Summary
BriaCell Therapeutics Corp. announced a manufacturing arrangement with FUJIFILM Biotechnologies California to support the ongoing pivotal Phase 3 clinical development and potential future commercial supply of its lead clinical candidate, Bria-IMT. This collaboration secures manufacturing capacity for Bria-IMT, an off-the-shelf allogenic cell therapy currently being evaluated in a Phase 3 study for advanced metastatic breast cancer. The agreement is a key milestone for BriaCell's development and commercialization strategy.
Key Highlights
- BriaCell entered a manufacturing arrangement with FUJIFILM Biotechnologies California.
- The partnership supports the pivotal Phase 3 study of Bria-IMT.
- It provides manufacturing capacity for Bria-IMT's commercial scalability.
- Bria-IMT is BriaCell's lead clinical candidate, an off-the-shelf allogenic cell therapy.
- Bria-IMT is being evaluated for advanced metastatic breast cancer.
Price Impact
More from BCTX